#ACC25#CircSimPub Two-year follow-up results of TRILUMINATE trial indicate significant reduction in tricuspid regurgitation severity & decreased HF hospitalization rates with tricuspid TEER compared to medical therapy. https://t.co/H9ef9xgLtt #AHAJournals@hahn_rt@tavrkapadia
Our physicians are proud to be part of a top-ranked cardiac program at TriStar Centennial - #1 in TN for cardiology for 2025 by Healthgrades and one of their top 100 hospitals for cardiac care, critical care, stroke care, and a top 50 program for vascular surgery.
We’ve been waiting a long time for these results! FlowTriever makes people feel better, faster than EKOS. Also appears to be a safer device. No change in RV/LV ratio at 24H. Almost all endpoints no different at 30 days. @PERTConsortium@crfheart#tct2024@SamHorrMD@ACCinTouch
Landmark PERSEVERE trial announced @escardio 2024
RCT for high risk massive PE: large bore thrombectomy vs standard of care.
Mortality 20-30% with standard of care
1 past RCT in this group with only 8 patients.
The “Golden Era of PE RCT” continues!
https://t.co/CWpUCqQz5n
The 1st Impella ECP case in Tennessee was performed today by Centennial Heart physicians. This new device is a smaller, low profile design which should improve the safety and quality of care of patients who are at higher risk during coronary stenting procedures. Congrats team!
You’re invited! Join us for a #PROTECTEDTAVR webinar on Monday, November 14, 3-4 pm CST. Drs. @SamHorrMD and @KendraGrubb will discuss stroke in #TAVR, the role and future of cerebral protection, and case examples. Register today! https://t.co/kSQlTiOBo4